Multiple pheochromocytomas and paragangliomas in a young patient carrying a SDHD gene mutation

European Journal of Pediatrics

Volumn 163, Issue 12, 2004, Pages 701-703

  Novosel, Astrid ^a   Heger, Alfred ^b   Lohse, Peter ^a   Schmidt, Heinrich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiotensin II receptor antagonist; Paraganglioma; Pheochromocytoma; SDHD gene

Indexed keywords

DOPAMINE; SUCCINATE DEHYDROGENASE;

ADOLESCENT; ADRENAL TUMOR; ANTIHYPERTENSIVE THERAPY; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; GENE MUTATION; GENETICS; GLOMUS TUMOR; HUMAN; HYPERTENSION; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; EXONS; GENE DELETION; GERM-LINE MUTATION; GUANINE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MEMBRANE PROTEINS; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SEQUENCE ANALYSIS, DNA; SUCCINATE DEHYDROGENASE;

EID: 11244269612     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-004-1538-2     Document Type: Article

References (13)

1. Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG, Eng C, Latif F, Maher ER (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet 357: 1181-1182
2. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C, Maher ER (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69: 49-54
3. Badenhop RF, Cherian S, Lord RS, Baysal BE, Taschner PE, Schofield PR (2001) Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss. Genes Chromosomes Cancer 31: 255-263
4. Baysal BE, Farr JE, Rubinstein WS, Galus RA, Johnson KA, Aston CE, Myers EN, Johnson JT, Carrau R, Kirkpatrick SJ, Myssiorek D, Singh D, Saha S, Gollin SM, Evans GA, James MR, Richard CW 3rd (1997) Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet 60: 121-132
5. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW 3rd, Cornelisse CJ, Devilee P, Devlin B (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851
6. Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL (2003) Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95: 1196-1204
7. Milunsky JM, Maher TA, Michels VV, Milunsky A (2001) Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 100: 311-314
8. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346: 1459-1466
9. Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma type 3. Nat Genet 26: 268-270
10. Niemann S, Muller U, Engelhardt D, Lohse P (2003) Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC. Hum Genet 113: 92-94
11. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS (2001) Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 134: 315-329
12. Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Brocker-Vriends AH, van der Mey AG, van Ommen GJ, Cornelisse CJ, Devilee P (2001) Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 31: 274-281
13. Wachtell K, Dahlof B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, Gerdts E, Boman K, Bella JN, Devereux RB (2002) Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Am Heart J 144: 1057-1064